SiranBio

News

GSK has extended its pipeline of siRNA drugs once again by licensing an ALK7-targeted therapy for cardiometabolic diseases from SiranBio.

News

Germany's government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.